MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0018382
Innosyn Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.04 Cr
▲ 26% YoY
Net profit · FY 2025
₹2.25 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹34 Lakh
EBITDA margin 11.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
9
Provident fund records
Directors on board
2
As per MCA filings
About Innosyn Life Sciences Private Limited
Data last updated:
Innosyn Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC117973. Its GSTIN is 36AAECI5451L1ZB (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramesh Babu Anagani (Managing Director) and Shilpa Gudibandla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.133/1/A Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.04 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹2.25 Lakh (net margin 0.7%) and EBITDA of ₹34 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 29% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Innosyn Life Sciences. Court records list 2 cases involving the company, including 2 filed against it.
Innosyn Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0018382). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innosynlifesciences.com.
Company Details of Innosyn Life Sciences Private Limited
CIN U74999TG2017PTC117973
Registration Number 117973
Incorporation Date 27 June 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0018382
Recognitions & Rankings of Innosyn Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.133/1/A Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, API Manufacturers
Comprehensive company report
Innosyn Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Innosyn Life Sciences Private Limited
Innosyn Life Sciences operates one associated brand: Innosyn Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Synthesis of pharmaceutical intermediates and provision of custom services in life sciences. | innosynlifesciences.com |
Business Activity of Innosyn Life Sciences Private Limited
The main business activity of Innosyn Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Innosyn Life Sciences Private Limited FY 2024 filings available
Innosyn Life Sciences Private Limited reported revenue of ₹3.04 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹3.04 Cr ▲ 26%
Net profit · FY 2025
₹2.25 Lakh margin 0.7%
EBITDA · FY 2025
₹34 Lakh margin 11.2%
Compounded Annual Growth Rate (CAGR) of Innosyn Life Sciences Private Limited
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 7%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 15%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 26% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Innosyn Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.25 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Innosyn Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Innosyn Life Sciences are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Innosyn Life Sciences Private Limited
Innosyn Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Babu Anagani | Managing Director | 27 Jun 2017 | 9 Years 3 Months | Current |
| Shilpa Gudibandla | Director | 27 Jun 2017 | 9 Years 3 Months | Current |
Peer Comparison of Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mekanar Pharma Private Limited | ₹3.2 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Hyderabad, Telangana, India |
| Cil Laboratories Private Limited | ₹3.14 Cr (FY 2023) | •••• | •••• | 26590.0% | •••• | Kolkata, West Bengal, India |
| Vvic Pharma Private Limited | ₹3.14 Cr (FY 2025) | •••• | •••• | 303.0% | •••• | Ankleshwar, Gujarat, India |
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | •••• | •••• | -53.0% | •••• | Walajapet, Tamil Nadu, India |
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | •••• | •••• | 1350.0% | •••• | Banaskatha, Gujarat, India |
| Innosyn Life Sciences Private Limited this company | ₹3.04 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Hyderabad, Telangana, India |
| Nic Bioscience Private Limited | ₹3.03 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ankleshwar, Gujarat, India |
| Vandana Life Sciences Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Hyderabad, Telangana, India |
| Pragna Chem Tech Private Limited | ₹2.77 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Ankleshwar, Gujarat, India |
| Nimp Healthcare Private Limited | ₹2.6 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Ankleshwar, Gujarat, India |
| Troikaa Pharmachem Private Limited | ₹2.57 Cr (FY 2025) | •••• | •••• | 5490.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Innosyn Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited is audited by SHEKARSANDA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHEKARSANDA | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Innosyn Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Chromachemie Laboratory Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Chromachemie Laboratory Private Limited | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Azole Chem Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited has a workforce of 9 employees as of Mar 29, 2024.
Employee count
9
Active EPFO establishments
1
Employee growth
28.57%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Innosyn Life Sciences Private Limited
Innosyn Life Sciences Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Cheguru Kumari Krishna ceased to be Director on 18 Mar 2019.
AGM
Innosyn Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Innosyn Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Cheguru Kumari Krishna ceased to be Director.
Ceased
Swathi Vuyyuru ceased to be Director.
Ceased
Nagaraju Marepu ceased to be Director.
Appointed
Ramesh Babu Anagani was appointed as Managing Director.
Appointed
Shilpa Gudibandla was appointed as Director.
Incorporation
27 Jun 2017
Innosyn Life Sciences Private Limited was registered on 27 Jun 2017 with Roc Hyderabad & aged 9 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Innosyn Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Innosyn Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Innosyn Life Sciences Private Limited
Innosyn Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECI5451L1ZB | Telangana | Active | 21 Aug 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Innosyn Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innosyn Life Sciences Private Limited
Innosyn Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 June 2017 (9+ years old) and is registered under CIN U74999TG2017PTC117973.
Innosyn Life Sciences reported revenue of ₹3.04 Cr for FY 2025 (up 26% YoY).
Innosyn Life Sciences has 2 current directors:
- Ramesh Babu Anagani - Managing Director
- Shilpa Gudibandla - Director
Innosyn Life Sciences reported a net profit of ₹2.25 Lakh (net margin 0.7%) and EBITDA of ₹34 Lakh (EBITDA margin 11.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Innosyn Life Sciences is 7% over three years and 29% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Innosyn Life Sciences is 36AAECI5451L1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Innosyn Life Sciences is U74999TG2017PTC117973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innosyn Life Sciences has 2 court cases on record: 2 filed against it.
Innosyn Life Sciences was incorporated on 27 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Innosyn Life Sciences by revenue are Mekanar Pharma Private Limited, Cil Laboratories Private Limited, Vvic Pharma Private Limited, Sthree Chemicals Private Limited, Supreme Drugs Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Cheguru Kumari Krishna ceased to be Director on 18 Mar 2019. Swathi Vuyyuru ceased to be Director on 07 Mar 2019. Nagaraju Marepu ceased to be Director on 24 Jul 2017. Innosyn Life Sciences has 5 board changes on record in total.
Yes, Innosyn Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0018382).